Myopia, Progressive Clinical Trial
Official title:
OCTA to Quantify the Parapapillary Choroidal Microvascular Changes in High Myopia
Myopia is a global healthy concern, especially the high myopia and pathological myopia among Asian populations. However, its mechanism still remains largely unclear. Recent findings suggested choroidal changes might be related to the development of myopia. This study is to useOCT angiography (OCT-A) to investigate parapapillary choroidal microvasculature change in myopic eyes, and try to find the cause-and-effect relationship between choroidal change and the development of myopia.
Status | Not yet recruiting |
Enrollment | 200 |
Est. completion date | December 31, 2030 |
Est. primary completion date | December 31, 2030 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 55 Years |
Eligibility |
Inclusion Criteria: 1. Spherical equivalent measurement can be included in above 4 groups 2. Willing to be followed up in the future 10 years Exclusion Criteria: 1. Deny to sign the patient consent, or deny to be followed 2. Evidence of cardiac, or diabetic, or CNS disease. 3. Clinically diagnosed with retinal or choroidal disease 4. Glucoma 5. Cataract or corneal disease that influence the quality of fundus OCTA image |
Country | Name | City | State |
---|---|---|---|
China | First Affiliated Hospital of Nanjing Medical University | Nanjing | Jiangsu |
Lead Sponsor | Collaborator |
---|---|
The First Affiliated Hospital with Nanjing Medical University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Parapapillary choroidal microvasculature void (MvV) area | area of parapapillary choroidal microvasculature void on OCTA images | changes of MvV area from at 10 years | |
Primary | Parapapillary choroidal microvasculature void (MvV) area | area of parapapillary choroidal microvasculature void on OCTA images | difference of MvV area in each group at baseline | |
Primary | Parapapillary choroidal microvasculature void (MvV) area | area of parapapillary choroidal microvasculature void on OCTA images | changes of MvV area at 1 years | |
Primary | Parapapillary choroidal microvasculature void (MvV) area | area of parapapillary choroidal microvasculature void on OCTA images | changes of MvV area at 3 years | |
Primary | Parapapillary choroidal microvasculature void (MvV) area | area of parapapillary choroidal microvasculature void on OCTA images | changes of MvV area at 5 years | |
Secondary | MvV number | number of choroidal MvV with certain size | baseline | |
Secondary | Correlation coefficient between choroidal MvV and refractive power | Correlation coefficient between choroidal MvV and refractive power | baseline | |
Secondary | Correlation coefficient between choroidal MvV and PPA area | Correlation coefficient between choroidal MvV and parapapillary atrophy beta area | baseline | |
Secondary | Correlation coefficient between choroidal MvV and choroid thickness | Correlation coefficient between choroidal MvV and choroid thickness | baseline | |
Secondary | Correlation coefficient between choroidal MvV and RNFL thickness | Correlation coefficient between choroidal MvV and RNFL thickness | baseline | |
Secondary | Correlation coefficient between choroidal MvV and Axial length | Correlation coefficient between choroidal MvV and Axial length | baseline | |
Secondary | Correlation coefficient between choroidal MvV and retinal parapapillary perfusion | Correlation coefficient between choroidal MvV and retinal parapapillary perfusion on OCTA images. | baseline | |
Secondary | Correlation coefficient between choroidal MvV and Macular perfusion | Correlation coefficient between choroidal MvV and Macular perfusion on OCTA images, Retinal parapapillary perfusion with OCTA. | baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05919654 -
Clinical Evaluation of MyoCare in Europe (CEME)
|
N/A | |
Recruiting |
NCT03402100 -
Eye Drops Study for Myopia Control in Schoolchildren
|
N/A | |
Recruiting |
NCT03865160 -
Low-dose Atropine for Myopia Control in Children
|
Phase 2/Phase 3 | |
Recruiting |
NCT06088225 -
Myopia Preventing With Distance-image Screen
|
N/A | |
Not yet recruiting |
NCT06085430 -
Kubota Glass Parameter Refinement Study
|
N/A | |
Not yet recruiting |
NCT06405711 -
To Evaluate the Efficacy and Safety of an Defocus Lens in Slowing the Progression of Myopia
|
N/A | |
Recruiting |
NCT05881655 -
Slow Myopia Progression With Different Irradiance Light
|
N/A | |
Recruiting |
NCT05761379 -
Clinical Study of Light Therapy to Control Myopia Progression in Children
|
N/A | |
Not yet recruiting |
NCT05760911 -
Myopia Prevention Through Monitoring and Motivating Outdoor Activities With Smartwatches
|
N/A | |
Recruiting |
NCT04722874 -
Repeated Low-Level Red-Light Therapy and Orthokeratology in Fast-progressing Myopia Control
|
N/A | |
Not yet recruiting |
NCT06221592 -
Differences and Wearing Safety and Comfort of New Defocus Incorporated Multiple Segments Spectacle Lenses
|
N/A | |
Completed |
NCT04806711 -
Eleven Years of Menicon Z Night Contact Lens Wear in Reducing Myopia Progression in Children
|
N/A | |
Completed |
NCT04806763 -
Myopia Control With Orthokeratology Contact Lenses in Spain
|
N/A | |
Completed |
NCT04806698 -
Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia
|
N/A | |
Recruiting |
NCT05894382 -
Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control
|
N/A | |
Completed |
NCT05683535 -
Adverse Events Related to Low Dose Atropine
|
||
Completed |
NCT05300321 -
DIMS-myopia Progression ADN Axial Length Growth
|
N/A | |
Withdrawn |
NCT03519490 -
Can Distance Center and Near Center Multifocal Contact Lenses Control Myopia Progression in Children?
|
N/A | |
Completed |
NCT05372991 -
Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05373693 -
Myopia-control Efficacy by Peripheral Defocus Lens (PDL)
|
N/A |